Laiken Alexa Sprenger, PA-C

Laiken Sprenger practices at UMiami Medicine - Dermatology in Miami, Florida.

Laiken Sprenger's NPI, 1699365122, was assigned on January 19, 2021. Laiken Sprenger holds Florida license PA9114225.

Laiken Sprenger's primary practice is UMiami Medicine - Dermatology, at 1444 NW 9th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-7688.

Laiken Sprenger's primary practice is UMiami Medicine - Dermatology in Miami, Florida. The medical group on file is University of Miami Health System. Dmand AI also links Laiken Sprenger to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Laiken Sprenger practices. Vendor and product names are available with a free account.

Physician assistant is Laiken Sprenger's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Laiken Sprenger is licensed in Florida.

Dmand AI lists acne, benign or precancerous skin growths, contact dermatitis, itchy rashes, scalp rash and skin cyst among the conditions Laiken Sprenger treats.

CMS data shows 123 Medicare services from Laiken Sprenger across 4 procedure codes in 2024, for 55 Medicare patients. Medicare paid $4,536 for them. Every service was in an office.

CMS counts 55 Medicare patients who saw Laiken Sprenger in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high cholesterol, and 65% have high blood pressure. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Laiken Sprenger's median patient age at 37, with 57% women.

In 2024, Laiken Sprenger wrote 130 Medicare Part D claims for 53 patients. 98% of them were for generic drugs. CMS names the drug for 73 of them, across 4 drugs with 11 or more claims each, at $772 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Laiken Sprenger for performance year 2024, reported as part of a group. Laiken Sprenger accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 14 general payments to Laiken Sprenger from 7 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 89% of the total. Bristol-Myers Squibb Company paid the most, $384.